Core Viewpoint - International Medical has achieved significant recognition in the healthcare sector in Xi'an, with its hospitals ranking highly in customer satisfaction and service quality [2][3] Summary by Categories Company Achievements - Xi'an International Medical Center Hospital ranked second in the "2024 Annual Customer Satisfaction Survey" for the entire healthcare industry in Shaanxi and received the "Best Service Unit" award [2][3] - Xi'an International Medical Center Hospital was also ranked first in the "Top 10 Single Hospitals in the Northwest Region" for the 2024-2025 period, while Xi'an High-tech Hospital secured the second position in the same category [2][3] Industry Positioning - The company is positioned as a representative comprehensive medical service listed company in the secondary market, having established a full-spectrum health service platform that covers medical services, rehabilitation, and elderly care [2][3] - The company has built a comprehensive medical service network that is deeply rooted in Xi'an, based in Shaanxi, and radiating throughout the central and western regions of China [2][3]

Core Insights - The company is a representative comprehensive medical service listed company in the secondary market, focusing on health care services and the application of modern medical technology [1] - It has established a service system with 10,000 hospital beds, creating a comprehensive health service platform that covers the entire life cycle from medical services to rehabilitation and elderly care [1] - The company has built a comprehensive medical service layout centered in Xi'an, with a focus on Shaanxi and the central and western regions of China [1] Financial Performance - The company has emphasized shareholder returns, having distributed cash dividends 16 times since its listing, totaling 576 million yuan [1] - In recent years, due to the impact of newly launched medical projects, the company's revenue has not yet covered operating costs and expenses, resulting in net losses [1] - Despite the losses, the overall medical business has maintained stable development, with a continuous reduction in the loss margin [1] Shareholder Engagement - The company repurchased shares in 2019 to implement equity incentives for the core team in 2021 and 2022 [1] - In 2021, the actual controller of the company encouraged all employees to increase their holdings in the company's stock [1] - In 2024, the chairman, vice chairman, and all senior management personnel will increase their shareholdings, and the company has also repurchased shares for cancellation to reduce registered capital, actively conveying confidence to the market [1]